Common antidepressant may ease long COVID’s crushing fatigue
A low-cost antidepressant may offer new hope for people struggling with long COVID fatigue. In a randomized clinical trial involving 399 adults, fluvoxamine significantly reduced fatigue and improved quality of life compared with a placebo, making it one of the first medications to show meaningful benefits for this disabling condition.
The Source
SD
Science
New AI blood test predicts heart disease 15 years early
SD·14h ago·3 min read
Science
A tiny universe in a bottle reveals clues to the origins of life
SD·16h ago·3 min read
Science
The mysterious hum heard around the world may finally have an explanation
SD·17h ago·3 min read
Science
Coffee may help the body fight stress and aging through a hidden cellular switch
SD·20h ago·3 min read
Related
On this beat
Science
‘Aliens’ at 40: James Cameron’s sequel is a sci-fi icon, but did you know he quit the movie twice?
SPACE·12h ago·3 min read
Science
New AI blood test predicts heart disease 15 years early
SD·14h ago·3 min read
Science
Should we trust AI in the search for alien life? Scientists aren’t so sure
SPACE·14h ago·3 min read
Science
How Christopher Nolan’s ‘Interstellar’ turned general relativity into the bad guy
SPACE·15h ago·3 min read